All
  • All
  • Company News
  • Press Releases
3rd-edition-of-fundamentals-of-solid-formulation-fsf2022-webinar-series

3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series

By J-Star Research | March 17, 2022
J-Star Research is pleased to announce our collaboration in the 3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series, featuring an impressive line-up of...
A group of people sitting around a table in a conference room.

Porton Announced To Acquire China Gateway Pharmaceutical Development Co., Ltd.

By news-24 | March 11, 2022
Expand small and medium-scale CDMO production capacity March 10th, 2022, Shanghai · China - Porton Pharma Solutions Ltd. announced that it is to acquire 100%...
A building with a blue sign on it.

Porton Plans To Invest 420 Million To Expand CDMO Production Capacity Of Small Molecule API

By news-24 | March 2, 2022
March 1st, 2022, Chongqing · China – Porton Pharma Solutions Ltd. announced an investment of 420 million to expand CDMO Production Capacity of Small Molecule...
A sign for porton technology in front of a brick building.

Porton Invests To Expand API CDMO Capacity

By news-24 | February 10, 2022
Chongqing China, February 10, 2022--Porton Pharma Solutions Ltd. (Porton) today announced it will expand its API CDMO production capacity with approximately RMB 260 million investment...
An aerial view of a city with mountains in the background.

Porton Expects Strongly Growth In Revenue And Net Profit In 2021

By news-24 | January 20, 2022
Chongqing · China: On January 16, 2022, Porton Pharma Solutions Ltd. released the "2021 Annual Performance Forecast". The company expects that revenue and net profit...
A group of people standing in front of a red banner.

Porton Joins Hands with Honeywell to Build the World-Class CDMO Platform

By news-24 | November 5, 2021
Subtitle: Enabling Public’s Early Access to Good Medicines On November 6, 2021, Porton Pharma Solutions Ltd. (hereinafter referred to as Porton,...
A poster with a blue and white background.

Porton Announces Third Quarter 2021 Results

By news-24 | November 2, 2021
j-star-researchs-subject-matter-experts-presenting-at-2021-aaps-pharmsci360-in-philadelphia

J-Star Research’s subject matter experts presenting at 2021 AAPS PharmSci360 in Philadelphia

By J-Star Research | October 13, 2021
J-Star Research’s subject matter experts are presenting at 2021 AAPS PharmSci360, in Philadelphia, PA, on October 17-20. Our synergistically integrated DS-DP team will discuss the...
porton-j-star-at-2021-sapa-annual-conference

Porton/J-Star at 2021 SAPA Annual Conference

By J-Star Research | September 21, 2021
We are proud to announce that Porton’s Chairman and CEO, Niafeng (Oliver) Ju (EMBA), and San Kiang (Ph.D.), CTO of Porton/J-Star Research, will be Keynote...
An aerial view of a large building in a forest.

Porton Announces Acquisition Of Yuyang Pharmaceutical To Expand Its Manufacturing Capacity

By news-24 | August 18, 2021
Chongqing, China，August 18, 2021-Porton Pharma Solutions Ltd. (Porton) today announced that it is to acquire 70% of equity of Hubei Yuyang Pharmaceutical Co., Ltd. (Yuyang)...
A white sheet with red and blue lines on it.

Porton Reports Strong Half-Year Results

By news-24 | August 16, 2021
j-star-research-exhibiting-at-cphi-north-america-august-10-12

J-Star Research Exhibiting at CPhI North America August 10-12

By J-Star Research | July 27, 2021
Visit J-Star Research and Porton at Booth 2243 from August 10th to 12th at this month's CPhINorthAmerica event. Our team will be available to discuss your drug...